Abstract
Inhibition of lymphangiogenesis prevents lymphatic cancer metastasis, whereas induction of lymphangiogenesis alleviates lymphedema in experimental animal models. The number of known molecular players that govern the formation and function of the microlymphatic system is growing. Here, we review the role of nitric oxide within the regulation of lymphatic formation and function and point out key unanswered questions for its translation into clinical therapy.
Original language | English |
---|---|
Article number | PII S1050-1738(05)00084-8 |
Pages (from-to) | 169-173 |
Number of pages | 5 |
Journal | Trends in Cardiovascular Medicine |
Volume | 15 |
Issue number | 5 |
DOIs | |
Publication status | Published - Jul 2005 |
Externally published | Yes |
Keywords
- GROWTH-FACTOR-C
- LYMPHATIC ENDOTHELIAL-CELLS
- PROGENITOR CELLS
- TISSUE ISCHEMIA
- IN-VIVO
- SYNTHASE
- LYMPHANGIOGENESIS
- ANGIOGENESIS
- METASTASIS
- VESSELS